Growth arrest in ovarian cancer cells by hTERT inhibition short-hairpin RNA targeting human telomerase reverse transcriptase induces immediate growth inhibition but not necessarily induces apoptosis in ovarian cancer cells

Cancer Investigation

Volumn 27, Issue 10, 2009, Pages 960-970

  Luo, Yi ^a   Yi, Yongfen ^a   Yao, Zhenwei ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; HTERT; P21; P53; Proliferation; Short term; Telomerase

Indexed keywords

P21 ACTIVATED KINASE; PROTEIN P53; SHORT HAIRPIN RNA; TELOMERASE REVERSE TRANSCRIPTASE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE ARREST; CELL CYCLE S PHASE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; KARYOTYPE; OVARY CANCER; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TELOMERE;

APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; HUMANS; MUTATION; OVARIAN NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TELOMERASE; TIME FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 70450213751     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357900802491451     Document Type: Article

References (35)

1. Takakura, M.; Kyo, S.; Kanaya, T.; Hirano, H.; Takeda, J.; Yutsudo, M.; Inoue, M. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res 1999, 59(3), 551-557.
2. Cong, Y.S.; Wen, J.; Bacchetti, S. The human telomerase catalytic subunit hTERT: Organization of the gene and characterization of the promoter. Hum Mol Genet 1999, 8(1), 137-142.
3. Kim, N.W.; Piatyszek,M.A.; Prowse, K.R.; Harley,C.B.;West, M.D.; Ho, P.L.; Coviello, G.M.; Wright, W.E.; Weinrich, S.L.; Shay, J.W. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266(5193), 2011-2015.
4. Shay, J.W.; Bacchetti, S. A survey of telomerase activity in human cancer. Eur. J. Cancer 1997, 33(5), 787-791.
5. Fakhoury, J.; Nimmo, G.A.; Autexier, C. Harnessing telomerase in cancer therapeutics. Anticancer Agents Med Chem 2007, 7 (4), 475-483.
6. Chen, S.M.; Tao, Z.Z.; Hua, Q.Q.; Xiao, B.K.; Xu, Y.; Wang, Y.; Deng, Y.Q. Inhibition of telomerase activity in cancer cells using short-hairpin RNA expression vectors. Cancer Investig 2007, 25(8), 691-698.
7. Kraemer, K.; Fuessel, S.; Schmidt, U.; Kotzsch, M.; Schwenzer, B.; Wirth, M.P.; Meye, A. Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells. Clin. Cancer Res 2003, 9(10), 3794-3800.
8. Ludwig, A.; Saretzki, G.; Holm, P.S.; Tiemann, F.; Lorenz, M.; Emrich, T.; Harley, C.B.; VonZglinicki, T. Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase. Cancer Res 2001, 61(7), 3053-3061.
9. Xu, D.; Wang, Q.; Gruber, A.; Bjorkholm, M.; Chen, Z.G.; Zaid, A.; Selivanova, G.; Peterson, C.; Wiman, K.G.; Pisa, P. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells. Oncogene 2000, 19(45), 5123-5133.
10. Kanaya, T.; Kyo, S.; Hamada, K.; Takakura, M.; Kitagawa, Y.; Harada, H.; Inoue, M. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription. Clin. Cancer Res 2000, 6(4), 1239-1247.
11. Serene, R.L.; Amanda, P.C.; Vu, Q.H.; Lucy, G.A.; Trygve, O.T. Evidence of extra-telomeric effects of hTERT and its regulation involving a feed back loop. Exp Cell Res 2007, 313(2), 322-330.
12. Perrault, S.D.; Hornsby, P.J.; Betts, D.H. Global gene expression response to telomerase in bovine adrenocortical cells. Biochem Biophys Res Commun 2005, 335(3), 925-936.
13. Eastman, A. Cell cycle checkpoints and their impact on anticancer therapeutic strategies. J Cell Biochem 2004, 91(2), 223-231.
14. Havrilesky, L.J.; Elbendary, A.; Hurteau, J.A.; Whitaker, R.S.; Rodriguez, G.C.; Berchuck, A. Chemotherapy-induced apoptosis in epithelial ovarian cancers. Obstet Gynecol 1995, 85(6), 1007-1010.
15. Gibb, R.K.; Taylor, D.D.; Wan, T.; O'Connor, D.M.; Doering, D.L.; Gercel-Taylor, C. Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian cancer cell lines. Gynecol Oncol 1997, 65(1), 13-22.
16. Saretzki, G.; Ludwig, A.; von Zglinicki, T.; Runnebaum, I.B. Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells. Cancer Gene Ther 2001, 8(10), 827-834.
17. Jerry, W.S. Telomerase therapeutics: Telomeres recognized as a DNA damage signal. Clin Cancer Res 2003, 9(10 pt 1), 3521-3525.
18. Tomlinson, R.L.; Ziegler, T.D.; Supakorndej, T.; Terns, R.M.; Terns, M.P. Cell cycle-regulated trafficking of human telomerase to telomeres. Mol Biol Cell 2006, 17 (2), 955-965.
19. Hagen, K.G. Ten; Gilbert, D.M.;Willard, H.F.; Cohen, S.N. Replication timing of DNA sequences associated with human centromeres and telomeres. Mol Cell Biol 1990, 10(12), 6348-6355.
20. Wright, W.E.; Tesmer, V.M.; Liao, M.L.; Shay, J.W. Normal human telomeres are not late replicating. Exp Cell Res 1999, 251(2), 492-499.
21. Yuebo, G.; Yiqun, M.; Jeffrey, J. Telomere maintenance in telomerase-positive human ovarian SKOV3 cells cannot be retarded by complete inhibition of telomerase. FEBS Lett 2002, 527 (1-3), 10-14.
22. Hwang, E.S.; Kim, J.; Kim, J.S.; Kao, C.; Ko, S.C.; Chung, L.; Lee, J.H. The effects of the adenovirus-mediated wild-type p53 delivery in human epithelial ovarian cancer cell line in vitro and in vivo. Int J Gynecol Cancer 1998, 8(1), 27-36.
23. Meulmeester, E.; Jochemsen, A.G. p53: A guide to apoptosis. Curr Cancer Drug Targets 2008, 8(2), 87-97.
24. Aime, A.L.; Alan, E. p53-based cancer therapies: Is defective p53 the Achilles heel of the tumor? Carcinogenesis 2007, 28(1), 13-20.
25. Gurova, K.V.; Rokhlin, O.W.; Budanov, A.V.; Burdelya, L.G.; Chumakov, P.M.; Cohen, M.B.; Gudkov, A.V. Cooperation of two mutant p53 alleles contributes to Fas resistance of prostate carcinoma cells. Cancer Res 2003, 63(11), 2905-2912.
26. Campomenosi, P.; Monti, P.; Aprile, A.; Abbondandolo, A.; Frebourg, T.; Gold, B.; Crook, T.; Inga, A.; Resnick, M.A.; Iggo, R.; Fronza, G. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements. Oncogene 2001, 20(27), 3573-3579.
27. el-Deiry, W.S.; Harper, J.W.; O'Connor, P.M.; Velculescu, V.E.; Canman, C.E.; Jackman, J.; Pietenpol, J.A.; Burrell, M.; Hill, D.E.; Wang, Y. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994, 54(5), 1169-1174.
28. Elbendary, A.A.; Cirisano, F.D.; Evans, A.C. Jr.; Davis, P.L.; Iglehart, J.D.; Marks, J.R.; Berchuck, A. Relationship between p21 expression and mutation of the p53 tumor suppressor gene in normal and malignant ovarian epithelial cells. Clin Cancer Res 1996, 2(9), 1571-1575.
29. Chattopadhyay, D.; Ghosh, M.K.; Mal, A.; Harter, M.L. Inactivation of p21 by E1A leads to the induction of apoptosis in DNA- damaged cells. J Virol 2001, 75(20), 9844-9856.
30. Pennington, K.N.; Taylor, J.A.; Bren, G.D.; Paya, C.V. IkappaB kinase-dependent chronic activation of NF-kappaB is necessary for p21 (WAF1/Cip1) inhibition of differentiation-induced apoptosis of monocytes. Mol Cell Biol 2001, 21(6), 1930-1941.
31. Mahyar-Roemer, M.; Roemer, K. p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53- independent apoptosis induced by natural chemopreventive and therapeutic agents. Oncogene 2001, 20(26), 3387-3398.
32. Goke, R.; Goke, A.; Goke, B.; El-Deiry,W.S.; Chen, Y. Pioglitazone inhibits growth of carcinoid cells and promotes TRAIL-induced apoptosis by induction of p21waf1/cip1. Digestion 2001, 64(2), 75-80.
33. Shin, B.A.; Ahn, K.Y.; Kook, H.; Koh, J.T.; Kang, I.C.; Lee, H.C.; Kim, K.K. Overexpressed human RAD50 exhibits cell death in a p21(WAF1/CIP1)-dependent manner: Its potential utility in local gene therapy of tumor. Cell Growth Differ 2001, 12(5), 243-254.
34. Ahmad, N.; Adhami, V.M.; Afaq, F.; Feyes, D.K.; Mukhtar, H. Resveratrol causes WAF-1/p21-mediated G1-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res 2001, 7 (5), 1466-1473.
35. Shibata, M.A.; Yoshidome, K.; Shibata, E.; Jorcyk, C.L.; Green, J.E. Suppression of mammary carcinoma growth in vitro and in vivo by inducible expression of the Cdk inhibitor p21. Cancer Gene Ther 2001, 8(1), 23-35.